newsfilter
← Latest News
PR Newswire·

Tetra Bio-Pharma Inc. Announces Termination of "At-The-Market" Offering

OTTAWA, ON, Nov. 4, 2021 /PRNewswire/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development, announced today the termination of its previously announced "at-